Here is why Statera Biopharma Inc. (STAB) stock volatility recorded over the last month was 9.38% – Invest Chronicle

Here is why Statera Biopharma Inc. (STAB) stock volatility recorded over the last month was 9.38%

Let’s start up with the current stock price of Statera Biopharma Inc. (STAB), which is $3.11 to be very precise. The Stock rose vividly during the last session to $3.30 after opening rate of $3.00 while the lowest price it went was recorded $2.89 before closing at $2.70.Recently in News on October 6, 2021, Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference. Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company will participate in the Alliance Global Partners (A.G.P.) Biotech and Specialty Pharma Conference taking place October 13, 2021. You can read further details here

Statera Biopharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.97 on 02/18/21, with the lowest value was $2.11 for the same time period, recorded on 10/08/21.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Statera Biopharma Inc. (STAB) full year performance was 42.66%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Statera Biopharma Inc. shares are logging -71.65% during the 52-week period from high price, and 47.39% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.11 and $10.97.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 530084 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Statera Biopharma Inc. (STAB) recorded performance in the market was -9.86%, having the revenues showcasing -24.88% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 78.65M, as it employees total of 2 workers.

Analysts verdict on Statera Biopharma Inc. (STAB)

During the last month, 0 analysts gave the Statera Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.08, with a change in the price was noted -2.12. In a similar fashion, Statera Biopharma Inc. posted a movement of -40.54% for the period of last 100 days, recording 210,956 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for STAB is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

>> 7 Top Picks for the Post-Pandemic Economy << 

Statera Biopharma Inc. (STAB): Technical Analysis

Raw Stochastic average of Statera Biopharma Inc. in the period of last 50 days is set at 39.22%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 74.63%. In the last 20 days, the company’s Stochastic %K was 49.13% and its Stochastic %D was recorded 29.28%.

Let’s take a glance in the erstwhile performances of Statera Biopharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -9.86%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -47.99%, alongside a boost of 42.66% for the period of the last 12 months. The shares 40.72% in the 7-day charts and went up by -4.60% in the period of the last 30 days. Common stock shares were lifted by -24.88% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam